Clinical trials
Completed Influenza, Human trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,685 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 7 |
| 2002 | 7 |
| 2003 | 9 |
| 2004 | 26 |
| 2005 | 56 |
| 2006 | 83 |
| 2007 | 100 |
| 2008 | 92 |
| 2009 | 180 |
| 2010 | 120 |
| 2011 | 82 |
| 2012 | 99 |
| 2013 | 107 |
| 2014 | 77 |
| 2015 | 68 |
| 2016 | 79 |
| 2017 | 65 |
| 2018 | 67 |
| 2019 | 54 |
| 2020 | 49 |
| 2021 | 55 |
| 2022 | 65 |
| 2023 | 56 |
| 2024 | 53 |
| 2025 | 14 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,685 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 170 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 145 |
| Sanofi Pasteur, a Sanofi Company | 113 |
| Novartis Vaccines | 59 |
| Seqirus | 49 |
| MedImmune LLC | 39 |
| Alachua Government Services, Inc. | 24 |
| Novartis | 23 |
| Stanford University | 20 |
| ModernaTX, Inc. | 19 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 1,685 |
| Virus Diseases | 81 |
| Orthomyxoviridae Infections | 64 |
| Influenza in Birds | 63 |
| Respiratory Tract Infections | 63 |
| COVID-19 | 52 |
| Infections | 41 |
| Common Cold | 36 |
| Respiratory Tract Diseases | 22 |
| RNA Virus Infections | 19 |
Trials
Showing 1 to 25 of 1,685. Each trial links to its page on Pharma Observatory.
1,585 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.